Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Cell Genesys, a biotechnology company, has reported a net loss of $13.3 million, or $0.15 per diluted share, for the fourth quarter of 2008, compared to a net loss of $33.4 million, or $0.43 per diluted share, for the corresponding period in 2007.
Subscribe to our email newsletter
Net loss for the year ended December 31, 2008 was $47 million, or $0.56 per diluted share, compared to a net loss of $99.3 million, or $1.39 per diluted share, for the year ended December 31, 2007.
The company reported revenues of $47.44 million for the fourth quarter of 2008, compared to $102,000 for the same period of 2007. For the year ended December 31, 2008, the company reported revenues of $94.57 million, compared to $1.38 million for 2007.